De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study

Tal Sella, Frederieke van Duijnhoven, Hans Wildiers, Claudio Venieri, Katarzyna Pogoda, Barbro Linderholm, Leonor Matos, Natali Shirron, Eleonora De Maio D'Esposito, Nawale Hajjaji, Erika Matos, Lucía González Cortijo, Matteo Lambertini, Ana Fortuna, Laurent Rosset, Anastasia Constantinidou, Sofie Demasure, Areen Abu Remilah, Greet Huygh, Shani Paluch-Shimon, Vivianne Tjan-Heijnen, Natacha Ruyssers, Helena Gouveia, Eurydice Angeli, Irfan Cicin, Edoardo Chiappe, Patrick Neven, Mehmet Artac, Bilgesah Kilictas, Jalal Baranseh, Elena Vicente-Rubio, Mustafa Atci, Ayelet Shai

Open source

DOI: 10.1016/j.breast.2026.104838
Published: 2026-08
Container: The Breast
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.breast.2026.104838,
  title = {De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study},
  author = {Tal Sella and Frederieke van Duijnhoven and Hans Wildiers and Claudio Venieri and Katarzyna Pogoda and Barbro Linderholm and Leonor Matos and Natali Shirron and Eleonora De Maio D'Esposito and Nawale Hajjaji and Erika Matos and Lucía González Cortijo and Matteo Lambertini and Ana Fortuna and Laurent Rosset and Anastasia Constantinidou and Sofie Demasure and Areen Abu Remilah and Greet Huygh and Shani Paluch-Shimon and Vivianne Tjan-Heijnen and Natacha Ruyssers and Helena Gouveia and Eurydice Angeli and Irfan Cicin and Edoardo Chiappe and Patrick Neven and Mehmet Artac and Bilgesah Kilictas and Jalal Baranseh and Elena Vicente-Rubio and Mustafa Atci and Ayelet Shai},
  year = {2026},
  journal = {The Breast},
  doi = {10.1016/j.breast.2026.104838},
  url = {https://doi.org/10.1016/j.breast.2026.104838}
}

RIS

TY  - JOUR
TI  - De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study
AU  - Tal Sella
AU  - Frederieke van Duijnhoven
AU  - Hans Wildiers
AU  - Claudio Venieri
AU  - Katarzyna Pogoda
AU  - Barbro Linderholm
AU  - Leonor Matos
AU  - Natali Shirron
AU  - Eleonora De Maio D'Esposito
AU  - Nawale Hajjaji
AU  - Erika Matos
AU  - Lucía González Cortijo
AU  - Matteo Lambertini
AU  - Ana Fortuna
AU  - Laurent Rosset
AU  - Anastasia Constantinidou
AU  - Sofie Demasure
AU  - Areen Abu Remilah
AU  - Greet Huygh
AU  - Shani Paluch-Shimon
AU  - Vivianne Tjan-Heijnen
AU  - Natacha Ruyssers
AU  - Helena Gouveia
AU  - Eurydice Angeli
AU  - Irfan Cicin
AU  - Edoardo Chiappe
AU  - Patrick Neven
AU  - Mehmet Artac
AU  - Bilgesah Kilictas
AU  - Jalal Baranseh
AU  - Elena Vicente-Rubio
AU  - Mustafa Atci
AU  - Ayelet Shai
PY  - 2026
JO  - The Breast
DO  - 10.1016/j.breast.2026.104838
UR  - https://doi.org/10.1016/j.breast.2026.104838
ER  -

APA

Sella, T., Duijnhoven, F. V., Wildiers, H., Venieri, C., Pogoda, K., Linderholm, B., Matos, L., Shirron, N., D'Esposito, E. D. M., Hajjaji, N., Matos, E., Cortijo, L. G., Lambertini, M., Fortuna, A., Rosset, L., Constantinidou, A., Demasure, S., Remilah, A. A., Huygh, G., Paluch-Shimon, S., Tjan-Heijnen, V., Ruyssers, N., Gouveia, H., Angeli, E., Cicin, I., Chiappe, E., Neven, P., Artac, M., Kilictas, B., Baranseh, J., Vicente-Rubio, E., Atci, M., & Shai, A. (2026). De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study. The Breast. https://doi.org/10.1016/j.breast.2026.104838

Source records

crossref · retrieved 2026-09-26T02:40:54.406Z